VIR

Trademark usage description

pharmaceutical anti-viral agents; pharmaceutical preparations for use in the treatment of infectious diseases and disorders, namely, hepatitis, influe Read More

Vienna Information

26 . 3 . 1

One triangleUn triangle

26 . 3 . 5

Triangles pointing downwardsTriangles avec la pointe en bas

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

29 . 1 . 8

BlackNoir

29 . 1 . 2

Yellow, goldJaune, or

Classification Information

Class [005]
Pharmaceutical anti-viral agents; pharmaceutical preparations for use in the treatment of infectious diseases and disorders, namely, hepatitis, influenza, HIV, COVID-19, respiratory syncytial virus (RSV), human metapneumovirus (MPV), and human papillomavirus (HPV), and in the field of oncology

Classification kind code

Mark Details

Serial Number

2189544

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 14^th Sept 2023	Search Recorded
Submitted for opposition 20 on 14^th Sept 2023	Examiner's First Report
Submitted for opposition 223 on 14^th Sept 2023	Total Provisional Refusal
Submitted for opposition 48 on 11^th Sept 2023	Agent Changed
Submitted for opposition 256 on 3^rd Apr 2023	Notification of Possible Opposition Sent
Submitted for opposition 257 on 2^th Jun 2022	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 1^st Jun 2022	Formalized
Submitted for opposition 1 on 1^st Jun 2022	Created
Submitted for opposition 228 on 11^th May 2022	International Registration
Submitted for opposition 30 on 11^th May 2022	Filed